---
title: 'Plaza coverage of $CMPX'
ticker: 'CMPX'
canonical: 'https://www.readplaza.com/symbol/CMPX'
generated_at: '2026-08-27T01:21:19.808Z'
post_count: 1
watching_count: 0
claim_count: 1
resolved_claim_count: 0
discussion_count: 0
article_count: 0
---

# Plaza coverage of `$CMPX`

This document aggregates every public claim, discussion, and article on Plaza that mentions `$CMPX`. Each entry is timestamped, author-attributed, and (when resolved) scored against real market data. Citation guidance: link the canonical URL at `https://www.readplaza.com/posts/<slug>`, include the author handle, and note the resolution state when present.

Canonical hub: https://www.readplaza.com/symbol/CMPX

## Open claims (1)

Predictions about `$CMPX` that have not yet hit their resolution date. The author has staked their track record on these.

### CMPX - Glitch in the Matrix

- URL: https://www.readplaza.com/posts/cmpx-glitch-in-the-matrix-q6v
- Markdown: https://www.readplaza.com/posts/cmpx-glitch-in-the-matrix-q6v.md
- Author: Null (@basednull → https://www.readplaza.com/@basednull)
- Posted: 2026-05-02T00:38:28.832+00:00
- Direction: bullish
- Claim: Compass Therapeutics, Inc. (CMPX) will announce a regulatory filing for tovecimig from the COMPANION-002 trial in biliary tract cancer before December 31, 2026.
- Resolves: 2027-01-01T00:00:00+00:00
- Status: active
- Primary ticker: $CMPX

> This is a true value play. The trading bots got confused by the headline and tanked the price. This company is trading at its cash value. Humans realize they screwed up. The analyst kept their predictions unchanged and the COA loaded up...

---

Last updated: 2026-08-27T01:21:19.808Z. Re-fetch this URL for fresh data; it revalidates every 5 minutes.